2008
DOI: 10.1093/cercor/bhm250
|View full text |Cite
|
Sign up to set email alerts
|

Low Striatal Glutamate Levels Underlie Cognitive Decline in the Elderly: Evidence from In Vivo Molecular Spectroscopy

Abstract: Glutamate (Glu), the principal excitatory neurotransmitter of prefrontal cortical efferents, potentially mediates higher order cognitive processes, and its altered availability may underlie mechanisms of age-related decline in frontally based functions. Although animal studies support a role for Glu in age-related cognitive deterioration, human studies, which require magnetic resonance spectroscopy for in vivo measurement of this neurotransmitter, have been impeded because of the similarity of Glu's spectrosco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

7
56
1

Year Published

2009
2009
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(64 citation statements)
references
References 100 publications
(118 reference statements)
7
56
1
Order By: Relevance
“…These opposing effects may have mitigated any age-related difference in overall Glx concentration here, but an underlying age-related imbalance may still account for the relationship with RAVLT performance. Outside of the hippocampus, age-related decreases in glutamate have been reported in the striatum (Zahr et al, 2008; but see Choi et al (2014) for the opposite pattern), but not the cerebellum (Zahr et al, 2008, 2013), emphasizing the possible regional specificity of these metabolic imbalances. Additionally, the opposing dynamics of the glutamate-glutamine cycle may be completely masked by the combined Glx metric.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…These opposing effects may have mitigated any age-related difference in overall Glx concentration here, but an underlying age-related imbalance may still account for the relationship with RAVLT performance. Outside of the hippocampus, age-related decreases in glutamate have been reported in the striatum (Zahr et al, 2008; but see Choi et al (2014) for the opposite pattern), but not the cerebellum (Zahr et al, 2008, 2013), emphasizing the possible regional specificity of these metabolic imbalances. Additionally, the opposing dynamics of the glutamate-glutamine cycle may be completely masked by the combined Glx metric.…”
Section: Discussionmentioning
confidence: 98%
“…Higher levels of glutamate in the striatum have been associated with better performance on tests of executive functioning in a group of older adults, provided a potential mechanism for age-related decline in the frontostriatal system (Zahr et al, 2008). N-methyl-D-asparate (NMDA) receptors represent one of the glutamate receptors that are present in high density in the hippocampus and cerebral cortex, even in aging and Alzheimer’s disease (Cotman et al, 1989), but there is mounting evidence that NMDA receptor function declines with age (Barnes et al, 1997).…”
Section: Discussionmentioning
confidence: 99%
“…The frontal cortex has been implicated in mediating many cognitive functions often found to be altered in multiple neurobehavioral disorders, including cognitive deficits, autism spectrum disorder (ASD), which affects an individuals social cognition, communication, and behavior, and schizophrenia (DeLorey et al 2008; Fatemi et al 2010; Gaspar et al 2009; Lewis and Sweet 2009; Mohler 2007; Zahr et al 2008). The frontal cortex is extensively innervated by the GABAergic, glutamatergic and dopaminergic neurotransmitter systems (Monaghan et al 1989; Rushworth et al 2007; Schoch et al 1985).…”
Section: 0 Introductionmentioning
confidence: 99%
“…Furthermore, reductions in striatal glutamate levels have correlated selectively with performance on cognitive tests showing age-related decline (Zahr et al, 2008). This is consistent with AVD deficiency in BALB/c male mice, in which we have shown an imbalance between excitatory and inhibitory neurotransmission with reductions in glutamate, glutamine and the enzymes GAD65 and 67, as well as increased levels of GABA across the whole brain (Groves et al, 2013).…”
Section: Discussionsupporting
confidence: 83%